The Impact of Letermovir (LTV) Prophylaxis on Early Cytomegalovirus Infection (CMVi) and Outcomes in the Adult Allogeneic Hematopoietic Cell Transplantation (alloHCT) Recipients with High- Risk Donor Type

被引:0
|
作者
Dadwal, Sanjeet S. [1 ]
Yang, Dongyun [2 ]
Marcucci, Guido [3 ]
Mokhtari, Sally [4 ]
Tegtmeier, Bernard [5 ]
Palmer, Joycelynne [6 ]
Smith, Eileen P. [7 ]
Taplitz, Randy [1 ]
Artz, Andrew S. [8 ]
Curtin, Peter T. [7 ]
Spielberger, Ricardo [7 ,9 ]
Salhotra, Amandeep [7 ]
Stein, Anthony S. [10 ]
Forman, Stephen J. [11 ]
Al Malki, Monzr M. [7 ]
Nakamura, Ryotaro [12 ]
机构
[1] City Hope Natl Med Ctr, Div Infect Dis, 1500 E Duarte Rd, Duarte, CA 91010 USA
[2] City Hope Natl Med Ctr, Dept Computat & Quantitat Med, 1500 E Duarte Rd, Duarte, CA 91010 USA
[3] City Hope Natl Med Ctr, Beckman Res Inst, Dept Hematol Malignancies Translat Sci, Gehr Family Ctr Leukemia Res,Hematol Malignancies, Duarte, CA 91010 USA
[4] City Hope Natl Med Ctr, Dept Clin Translat Program Dev, 1500 E Duarte Rd, Duarte, CA 91010 USA
[5] City Hope Natl Med Ctr, Dept Qual Risk & Regulatory Management, 1500 E Duarte Rd, Duarte, CA 91010 USA
[6] City Hope Natl Med Ctr, Dept Computat & Quantitat Med BRI, 1500 E Duarte Rd, Duarte, CA 91010 USA
[7] City Hope Natl Med Ctr, Dept Hematol HCT, 1500 E Duarte Rd, Duarte, CA 91010 USA
[8] City Hope Natl Med Ctr, Dept Hematol HCT, Duarte, CA USA
[9] Southern Calif Kaiser Permanente, Bone Marrow Transplant Program, Los Angeles, CA USA
[10] City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA
[11] City Hope Natl Med Ctr, Beckman Res Inst, Dept Hematol HCT, Duarte, CA USA
[12] City Hope Natl Med Ctr, Dept Hematol & Hematopoiet Cell Transplantat, Duarte, CA USA
关键词
D O I
10.1182/blood-2021-153784
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1776
引用
收藏
页码:1776 / +
页数:6
相关论文
共 50 条
  • [31] Risk-Adapted Letermovir Prophylaxis Based on a Scoring System Predicting a Higher Burden of Cytomegalovirus Exposure After Allogeneic Hematopoietic Cell Transplantation
    Kawamura, Shunto
    Fujiwara, Shin-ichiro
    Kimura, Shun-ichi
    Takeshita, Junko
    Nakasone, Hideki
    Yoshimura, Kazuki
    Nakata, Yuya
    Ishikawa, Takuto
    Matsuoka, Akari
    Meno, Tomohiro
    Nakamura, Yuhei
    Kawamura, Masakatsu
    Yoshino, Nozomu
    Misaki, Yukiko
    Gomyo, Ayumi
    Kusuda, Machiko
    Murahashi, Rui
    Umino, Kento
    Minakata, Daisuke
    Ashizawa, Masahiro
    Yamamoto, Chihiro
    Hatano, Kaoru
    Sato, Kazuya
    Ohmine, Ken
    Kako, Shinichi
    Kanda, Yoshinobu
    TRANSPLANTATION AND CELLULAR THERAPY, 2025, 31 (03): : 184e1 - 184e11
  • [32] Occurrence, risk factors and outcome of adenovirus infection in adult recipients of allogeneic hematopoietic stem cell transplantation
    Hubmann, Max
    Fritsch, Susanne
    Zoellner, Anna-Katharina
    Prevalsek, Dusan
    Engel, Nicole
    Buecklein, Veit
    Mumm, Friederike
    Schulz, Christoph
    Stemmler, Hans Joachim
    Jaeger, Gundula
    Ledderose, Georg
    Kolb, Hans Jochem
    Hausmann, Andreas
    Hiddemann, Wolfgang
    Moosmann, Andreas
    Tischer, Johanna
    JOURNAL OF CLINICAL VIROLOGY, 2016, 82 : 33 - 40
  • [33] Risk factors associated with the development of clinically significant cytomegalovirus (CMV) infection in the allogeneic hematopoietic-cell transplant (HCT) letermovir prophylaxis trial
    Marty, Francisco M.
    Ellison, Misoo C.
    Rabitsch, Werner
    Itala-Remes, Maija
    Dominietto, Alida
    Peggs, Karl
    Browett, Peter
    Moreno, Mariela
    Leavitt, Randi Y.
    Joshi, Amita
    Badshah, Cyrus
    Yeh, Wendy W.
    BONE MARROW TRANSPLANTATION, 2019, 54 : 101 - 102
  • [34] Letermovir for CMV Prophylaxis in Very High-Risk Pediatric Hematopoietic Stem Cell Transplantation Recipients for Inborn Errors of Immunity
    Thibaut César
    Minh P. Le
    Roman Klifa
    Martin Castelle
    Benjamin Fournier
    Romain Lévy
    Marwa Chbihi
    Virginie Courteille
    Despina Moshous
    Stéphane Blanche
    Mickaël Alligon
    Marianne Leruez-Ville
    Gilles Peytavin
    Pierre Frange
    Bénédicte Neven
    Journal of Clinical Immunology, 2024, 44
  • [35] Real-world efficacy of letermovir prophylaxis for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation: A single-center retrospective analysis
    Yoshimura, Hideaki
    Satake, Atsushi
    Ishii, Yuka
    Ichikawa, Jun
    Saito, Ryo
    Konishi, Akiko
    Hotta, Masaaki
    Nakanishi, Takahisa
    Fujita, Shinya
    Ito, Tomoki
    Ishii, Kazuyoshi
    Nomura, Shosaku
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2022, 28 (09) : 1317 - 1323
  • [36] Letermovir for CMV Prophylaxis in Very High-Risk Pediatric Hematopoietic Stem Cell Transplantation Recipients for Inborn Errors of Immunity
    Cesar, Thibaut
    Le, Minh P.
    Klifa, Roman
    Castelle, Martin
    Fournier, Benjamin
    Levy, Romain
    Chbihi, Marwa
    Courteille, Virginie
    Moshous, Despina
    Blanche, Stephane
    Alligon, Mickael
    Leruez-Ville, Marianne
    Peytavin, Gilles
    Frange, Pierre
    Neven, Benedicte
    JOURNAL OF CLINICAL IMMUNOLOGY, 2024, 44 (01)
  • [37] The clinical impact of cytomegalovirus infection following allogeneic hematopoietic cell transplantation: Why the quest for meaningful prophylaxis still matters
    Chan, Shawna T.
    Logan, Aaron C.
    BLOOD REVIEWS, 2017, 31 (03) : 173 - 183
  • [38] Haploidentical allogeneic hematopoietic stem cell transplantation increases the risk of cytomegalovirus infection in adult patients with acute leukemia
    Lin, Cheng-Hsien
    Su, Yi-Jiun
    Hsu, Chiann-Yi
    Wang, Po-Nan
    Teng, Chieh-Lin Jerry
    TRANSPLANT INFECTIOUS DISEASE, 2019, 21 (04)
  • [39] Letermovir vs. high-dose valacyclovir for cytomegalovirus prophylaxis following haploidentical or mismatched unrelated donor allogeneic hematopoietic cell transplantation receiving post-transplant cyclophosphamide
    Freyer, Craig W.
    Carulli, Alison
    Gier, Shannon
    Ganetsky, Alex
    Timlin, Colleen
    Schuster, Mindy
    Babushok, Daria
    Frey, Noelle, V
    Gill, Saar, I
    Hexner, Elizabeth O.
    Luger, Selina M.
    Mangan, James K.
    Martin, Mary Ellen
    McCurdy, Shannon R.
    Perl, Alexander E.
    Porter, David L.
    Pratz, Keith
    Smith, Jacqueline
    Stadtmauer, Edward A.
    Loren, Alison W.
    LEUKEMIA & LYMPHOMA, 2022, 63 (08) : 1925 - 1933
  • [40] PROPHYLAXIS OF INVASIVE FUNGAL INFECTION WITH VORICONAZOLE IN HIGH-RISK ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
    Gutierrez, L.
    Martinez-Mugica, C.
    Gonzalez, A. J.
    Solano, J.
    Duenas, V.
    Palomo, P.
    Gonzalez, A. P.
    Gonzalez, S.
    Rayon, C.
    Vallejo, C.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S467 - S467